AU502146B2 - 11-epi-prostanoic acid derivatives - Google Patents

11-epi-prostanoic acid derivatives

Info

Publication number
AU502146B2
AU502146B2 AU83102/75A AU8310275A AU502146B2 AU 502146 B2 AU502146 B2 AU 502146B2 AU 83102/75 A AU83102/75 A AU 83102/75A AU 8310275 A AU8310275 A AU 8310275A AU 502146 B2 AU502146 B2 AU 502146B2
Authority
AU
Australia
Prior art keywords
epi
acid derivatives
prostanoic acid
prostanoic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU83102/75A
Other languages
English (en)
Other versions
AU8310275A (en
Inventor
J. Maloon K. B Bowler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of AU8310275A publication Critical patent/AU8310275A/en
Application granted granted Critical
Publication of AU502146B2 publication Critical patent/AU502146B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU83102/75A 1974-08-05 1975-07-16 11-epi-prostanoic acid derivatives Expired AU502146B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB34334/74A GB1486832A (en) 1974-08-05 1974-08-05 Prostanoic acid derivatives
GBGB34334/74 1974-08-05

Publications (2)

Publication Number Publication Date
AU8310275A AU8310275A (en) 1977-01-20
AU502146B2 true AU502146B2 (en) 1979-07-12

Family

ID=10364354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83102/75A Expired AU502146B2 (en) 1974-08-05 1975-07-16 11-epi-prostanoic acid derivatives

Country Status (17)

Country Link
JP (1) JPS51125042A (nl)
AT (1) ATA606175A (nl)
AU (1) AU502146B2 (nl)
BE (1) BE832098A (nl)
CA (1) CA1067490A (nl)
DD (1) DD124595A5 (nl)
DE (1) DE2534989A1 (nl)
DK (1) DK354575A (nl)
FI (1) FI752196A (nl)
FR (1) FR2281101A1 (nl)
GB (1) GB1486832A (nl)
IE (1) IE43198B1 (nl)
IN (1) IN141386B (nl)
NL (1) NL7509078A (nl)
NO (1) NO752734L (nl)
SE (1) SE7508779L (nl)
ZA (1) ZA754491B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554030A (en) * 1976-05-10 1979-10-17 Upjohn Co Prostaglandins
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension

Also Published As

Publication number Publication date
FI752196A (nl) 1976-02-06
CA1067490A (en) 1979-12-04
GB1486832A (en) 1977-09-28
FR2281101A1 (fr) 1976-03-05
JPS51125042A (en) 1976-11-01
ATA606175A (de) 1978-05-15
DE2534989A1 (de) 1976-02-26
IE43198L (en) 1976-02-05
NL7509078A (nl) 1976-02-09
SE7508779L (sv) 1976-02-06
ZA754491B (en) 1976-06-30
BE832098A (fr) 1976-02-04
DK354575A (da) 1976-02-06
IN141386B (nl) 1977-02-19
NO752734L (nl) 1976-02-06
FR2281101B1 (nl) 1978-11-10
IE43198B1 (en) 1981-01-14
DD124595A5 (nl) 1977-03-02
AU8310275A (en) 1977-01-20

Similar Documents

Publication Publication Date Title
AU521892B2 (en) Sulphamoylbenzoic acid derivatives
AU500910B2 (en) Benzimidazolinone derivatives
AU498132B2 (en) 5 - nitro - pyrimidine derivatives
AU470711B2 (en) Oxacyclohexane derivatives
AU502146B2 (en) 11-epi-prostanoic acid derivatives
AU501915B2 (en) Phenyl-pyridylamine derivatives
AU503060B2 (en) Ergopeptine derivatives
AU500572B2 (en) Isoclavulanic acid derivatives
AU472498B2 (en) Aminomethylarylmethlpenicillin derivatives
AU486554B2 (en) 2-chloroethanephosphonic acid derivatives
AU482042B2 (en) Thienopyridine-carboxylic acid derivatives
AU8095975A (en) Thiaprostanoic acid derivatives
AU7782675A (en) 2-chloroethanephosphonic acid derivatives
AU8128975A (en) Phenylene-dioxamic acid derivatives
AU8616975A (en) Furanhydroxamic acid derivatives
AU482719B2 (en) Prostanoic acid derivatives
AU491537B2 (en) 16-oxygenated prostanoic acid derivatives
AU488164B2 (en) Pyrimidincl derivatives
AU480360B2 (en) 2-aminomethyl-phenol derivatives
AU486830B2 (en) Benzo-bicyclononene derivatives
AU485016B2 (en) Mercaptomethylpyridine derivatives
AU496294B2 (en) Phenoxyhydroxypropylamine derivatives
AU493443B2 (en) N-substituted-acetyl n-substituted-aniline derivatives
AU493074B2 (en) Thiepino- and oxepino - pyrrole derivatives
AU491426B2 (en) N-thiobenzoyl-n-halophenylalamine derivatives